Pactiv Evergreen (PTVE) Stock Forecast, Price Target & Predictions
PTVE Stock Forecast
Pactiv Evergreen stock forecast is as follows: an average price target of $15.50 (represents a 38.15% upside from PTVE’s last price of $11.22) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
PTVE Price Target
The average price target for Pactiv Evergreen (PTVE) is $15.50 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $17.00 to $14.00. This represents a potential 38.15% upside from PTVE's last price of $11.22.
PTVE Analyst Ratings
According to 6 Wall Street analysts, Pactiv Evergreen's rating consensus is 'Buy'. The analyst rating breakdown for PTVE stock is 0 'Strong Buy' (0.00%), 5 'Buy' (83.33%), 1 'Hold' (16.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Pactiv Evergreen Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 06, 2024 | Arun Viswanathan | RBC Capital | $17.00 | $13.57 | 25.28% | 51.52% |
| Mar 04, 2024 | Pactiv Evergreen | Goldman Sachs | $14.00 | $13.18 | 6.22% | 24.78% |
| Nov 14, 2022 | - | Goldman Sachs | $12.00 | $11.54 | 3.99% | 6.95% |
The latest Pactiv Evergreen stock forecast, released on May 06, 2024 by Arun Viswanathan from RBC Capital, set a price target of $17.00, which represents a 25.28% increase from the stock price at the time of the forecast ($13.57), and a 51.52% increase from PTVE last price ($11.22).
Pactiv Evergreen Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $15.50 |
| Last Closing Price | $11.22 | $11.22 | $11.22 |
| Upside/Downside | -100.00% | -100.00% | 38.15% |
In the current month, the average price target of Pactiv Evergreen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Pactiv Evergreen's last price of $11.22. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 08, 2024 | Citigroup | Buy | Buy | Hold |
| May 06, 2024 | RBC Capital | Outperform | Outperform | Hold |
| May 06, 2024 | Bank of America Securities | Buy | Buy | Hold |
| Apr 04, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Apr 04, 2024 | UBS | Buy | Buy | Hold |
| Apr 04, 2024 | Citigroup | Buy | Buy | Hold |
| Mar 04, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Mar 04, 2024 | UBS | Buy | Buy | Hold |
| Mar 04, 2024 | Citigroup | Buy | Buy | Hold |
| Mar 04, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Pactiv Evergreen's last stock rating was published by Citigroup on Jul 08, 2024. The company gave PTVE a "Buy" rating, the same as its previous rate.
Pactiv Evergreen Financial Forecast
Pactiv Evergreen Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.18B | $1.38B | $1.43B | $1.43B | $1.48B | $1.61B | $1.64B | $1.50B | $1.53B | $1.39B | $1.35B | $1.16B | $1.18B | $1.20B |
| Avg Forecast | $1.36B | $1.44B | $1.42B | $1.30B | $1.33B | $1.41B | $1.39B | $1.27B | $1.26B | $1.37B | $1.36B | $1.29B | $1.32B | $1.39B | $1.55B | $1.44B | $1.49B | $1.48B | $1.61B | $1.35B | $1.48B | $1.33B | $1.23B | $1.03B | $1.21B | $1.19B |
| High Forecast | $1.36B | $1.44B | $1.42B | $1.30B | $1.33B | $1.41B | $1.39B | $1.27B | $1.26B | $1.37B | $1.36B | $1.29B | $1.32B | $1.39B | $1.55B | $1.44B | $1.49B | $1.48B | $1.61B | $1.35B | $1.48B | $1.33B | $1.23B | $1.03B | $1.21B | $1.19B |
| Low Forecast | $1.36B | $1.44B | $1.42B | $1.30B | $1.33B | $1.41B | $1.39B | $1.27B | $1.26B | $1.37B | $1.36B | $1.29B | $1.32B | $1.39B | $1.55B | $1.44B | $1.49B | $1.48B | $1.61B | $1.35B | $1.48B | $1.33B | $1.23B | $1.03B | $1.21B | $1.19B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.99% | 0.92% | 1.00% | 0.99% | 1.08% | 1.02% | 1.11% | 1.03% | 1.05% | 1.10% | 1.12% | 0.97% | 1.00% |
Pactiv Evergreen's average Quarter revenue forecast for Mar 24 based on 2 analysts is $1.29B, with a low forecast of $1.29B, and a high forecast of $1.29B. PTVE's average Quarter revenue forecast represents a 9.20% increase compared to the company's last Quarter revenue of $1.18B (Dec 23).
Pactiv Evergreen EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $83.00M | $113.00M | $-80.00M | $158.00M | $160.00M | $215.00M | $256.00M | $185.00M | $51.00M | $150.00M | $131.00M | $79.00M | $342.00M | $-169.00M |
| Avg Forecast | $191.32M | $202.70M | $199.31M | $182.89M | $187.55M | $198.77M | $195.49M | $179.30M | $177.99M | $193.29M | $191.07M | $116.16M | $185.55M | $195.73M | $217.86M | $91.83M | $81.02M | $208.79M | $225.91M | $72.59M | $207.96M | $186.75M | $172.65M | $233.61M | $170.71M | $-2.93B |
| High Forecast | $191.32M | $202.70M | $199.31M | $182.89M | $187.55M | $198.77M | $195.49M | $179.30M | $177.99M | $193.29M | $191.07M | $139.40M | $185.55M | $195.73M | $217.86M | $110.20M | $97.22M | $208.79M | $225.91M | $87.11M | $207.96M | $186.75M | $172.65M | $280.34M | $170.71M | $-2.34B |
| Low Forecast | $191.32M | $202.70M | $199.31M | $182.89M | $187.55M | $198.77M | $195.49M | $179.30M | $177.99M | $193.29M | $191.07M | $92.93M | $185.55M | $195.73M | $217.86M | $73.46M | $64.82M | $208.79M | $225.91M | $58.07M | $207.96M | $186.75M | $172.65M | $186.89M | $170.71M | $-3.52B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.45% | 0.58% | -0.37% | 1.72% | 1.97% | 1.03% | 1.13% | 2.55% | 0.25% | 0.80% | 0.76% | 0.34% | 2.00% | 0.06% |
2 analysts predict PTVE's average Quarter EBITDA for Mar 24 to be $116.16M, with a high of $139.40M and a low of $92.93M. This is 39.96% upper than Pactiv Evergreen's previous annual EBITDA (Dec 23) of $83.00M.
Pactiv Evergreen Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $21.00M | $72.00M | $-139.00M | $-133.00M | $26.00M | $176.00M | $73.00M | $43.00M | $78.00M | - | $7.00M | $-15.00M | $236.00M | $-359.00M |
| Avg Forecast | $82.46M | $92.85M | $52.75M | $42.29M | $64.23M | $73.34M | $46.25M | $40.06M | $60.15M | $66.01M | $46.38M | $35.68M | $35.21M | $33.41M | $38.75M | $28.20M | $50.84M | $30.25M | $40.08M | $22.30M | $76.98M | $22.32M | $27.78M | $-44.36M | $44.75M | $-6.23B |
| High Forecast | $82.46M | $92.85M | $52.75M | $42.29M | $64.23M | $73.34M | $46.25M | $40.06M | $60.15M | $78.01M | $46.40M | $42.81M | $50.30M | $33.45M | $38.75M | $33.85M | $61.00M | $30.25M | $40.08M | $26.76M | $76.98M | $22.32M | $27.78M | $-35.49M | $44.75M | $-4.98B |
| Low Forecast | $82.46M | $92.85M | $52.75M | $42.29M | $64.23M | $73.34M | $46.25M | $40.06M | $60.15M | $54.00M | $46.36M | $28.54M | $20.12M | $33.38M | $38.75M | $22.56M | $40.67M | $30.25M | $40.08M | $17.84M | $76.98M | $22.32M | $27.78M | $-53.23M | $44.75M | $-7.47B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.60% | 2.15% | -3.59% | -4.72% | 0.51% | 5.82% | 1.82% | 1.93% | 1.01% | - | 0.25% | 0.34% | 5.27% | 0.06% |
Pactiv Evergreen's average Quarter net income forecast for Mar 24 is $35.68M, with a range of $28.54M to $42.81M. PTVE's average Quarter net income forecast represents a 69.90% increase compared to the company's last Quarter net income of $21.00M (Dec 23).
Pactiv Evergreen SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $133.00M | $137.00M | $136.00M | $130.00M | $148.00M | $145.00M | $148.00M | $142.00M | $-121.00M | $104.00M | $115.00M | $126.00M | $112.00M | $116.00M |
| Avg Forecast | $126.72M | $134.26M | $132.02M | $121.14M | $124.22M | $131.66M | $129.48M | $118.76M | $117.89M | $128.03M | $126.55M | $117.82M | $122.90M | $129.64M | $144.30M | $93.14M | $-192.22M | $138.29M | $149.63M | $73.63M | $137.74M | $123.70M | $114.36M | $372.60M | $113.07M | $111.34M |
| High Forecast | $126.72M | $134.26M | $132.02M | $121.14M | $124.22M | $131.66M | $129.48M | $118.76M | $117.89M | $128.03M | $126.55M | $141.39M | $122.90M | $129.64M | $144.30M | $111.77M | $-153.78M | $138.29M | $149.63M | $88.36M | $137.74M | $123.70M | $114.36M | $447.12M | $113.07M | $111.34M |
| Low Forecast | $126.72M | $134.26M | $132.02M | $121.14M | $124.22M | $131.66M | $129.48M | $118.76M | $117.89M | $128.03M | $126.55M | $94.26M | $122.90M | $129.64M | $144.30M | $74.51M | $-230.67M | $138.29M | $149.63M | $58.90M | $137.74M | $123.70M | $114.36M | $298.08M | $113.07M | $111.34M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.06% | 0.94% | 1.40% | -0.77% | 1.05% | 0.99% | 1.93% | -0.88% | 0.84% | 1.01% | 0.34% | 0.99% | 1.04% |
Pactiv Evergreen's average Quarter SG&A projection for Mar 24 is $117.82M, based on 2 Wall Street analysts, with a range of $94.26M to $141.39M. The forecast indicates a -11.41% fall compared to PTVE last annual SG&A of $133.00M (Dec 23).
Pactiv Evergreen EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.12 | $0.16 | $-0.78 | $-0.75 | $0.15 | $0.99 | $0.41 | $0.24 | $0.44 | - | $0.04 | $-0.09 | $0.10 | $-2.59 |
| Avg Forecast | $0.46 | $0.51 | $0.29 | $0.23 | $0.35 | $0.41 | $0.26 | $0.22 | $0.33 | $0.36 | $0.26 | $0.09 | $0.19 | $0.18 | $0.21 | $0.07 | $0.05 | $0.17 | $0.22 | $0.10 | $0.43 | $0.12 | $0.15 | $0.07 | $0.25 | $0.15 |
| High Forecast | $0.46 | $0.51 | $0.29 | $0.23 | $0.35 | $0.41 | $0.26 | $0.22 | $0.33 | $0.43 | $0.26 | $0.09 | $0.28 | $0.18 | $0.21 | $0.07 | $0.05 | $0.17 | $0.22 | $0.10 | $0.43 | $0.12 | $0.15 | $0.07 | $0.25 | $0.15 |
| Low Forecast | $0.46 | $0.51 | $0.29 | $0.23 | $0.35 | $0.41 | $0.26 | $0.22 | $0.33 | $0.30 | $0.26 | $0.09 | $0.11 | $0.18 | $0.21 | $0.07 | $0.05 | $0.17 | $0.22 | $0.10 | $0.43 | $0.12 | $0.15 | $0.07 | $0.25 | $0.15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.62% | 0.87% | -3.64% | -10.21% | 2.84% | 5.92% | 1.85% | 2.30% | 1.03% | - | 0.26% | -1.31% | 0.40% | -17.61% |
According to 2 Wall Street analysts, Pactiv Evergreen's projected average Quarter EPS for Mar 24 is $0.09, with a low estimate of $0.09 and a high estimate of $0.09. This represents a -28.19% decrease compared to PTVE previous annual EPS of $0.12 (Dec 23).
Pactiv Evergreen Peer Comparison by Price Target
PTVE Forecast FAQ
Is Pactiv Evergreen a good buy?
Yes, according to 6 Wall Street analysts, Pactiv Evergreen (PTVE) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 83.33% of PTVE's total ratings.
What is PTVE's price target?
Pactiv Evergreen (PTVE) average price target is $15.5 with a range of $14 to $17, implying a 38.15% from its last price of $11.22. The data is based on 6 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Pactiv Evergreen stock go up soon?
According to Wall Street analysts' prediction for PTVE stock, the company can go up by 38.15% (from the last price of $11.22 to the average price target of $15.5), up by 51.52% based on the highest stock price target, and up by 24.78% based on the lowest stock price target.
Can Pactiv Evergreen stock reach $20?
PTVE's average twelve months analyst stock price target of $15.5 does not support the claim that Pactiv Evergreen can reach $20 in the near future.
What are Pactiv Evergreen's analysts' financial forecasts?
Pactiv Evergreen's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $5.41B (high $5.41B, low $5.41B), average EBITDA is $761.11M (high $761.11M, low $761.11M), average net income is $223.88M (high $223.88M, low $223.88M), average SG&A $504.12M (high $504.12M, low $504.12M), and average EPS is $1.24 (high $1.24, low $1.24). PTVE's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $5.52B (high $5.52B, low $5.52B), average EBITDA is $776.21M (high $776.21M, low $776.21M), average net income is $270.36M (high $270.36M, low $270.36M), average SG&A $514.13M (high $514.13M, low $514.13M), and average EPS is $1.49 (high $1.49, low $1.49).
Did the PTVE's actual financial results beat the analysts' financial forecasts?
Based on Pactiv Evergreen's last annual report (Dec 2023), the company's revenue was $5.12B, which missed the average analysts forecast of $5.69B by -10.02%. Apple's EBITDA was $28M, missing the average prediction of $690.97M by -95.95%. The company's net income was $-223M, missing the average estimation of $135.58M by -264.48%. Apple's SG&A was $536M, beating the average forecast of $489.98M by 9.39%. Lastly, the company's EPS was $-1.25, missing the average prediction of $0.667 by -287.51%. In terms of the last quarterly report (Dec 2023), Pactiv Evergreen's revenue was $1.18B, missing the average analysts' forecast of $1.32B by -10.20%. The company's EBITDA was $83M, missing the average prediction of $185.55M by -55.27%. Pactiv Evergreen's net income was $21M, missing the average estimation of $35.21M by -40.36%. The company's SG&A was $133M, beating the average forecast of $122.9M by 8.22%. Lastly, the company's EPS was $0.12, missing the average prediction of $0.195 by -38.32%